Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1998 Sep;57(9):509–510. doi: 10.1136/ard.57.9.509

Hyperlipidaemia in hyperuricaemia and gout

B EMMERSON 1
PMCID: PMC1752735  PMID: 9849306

Full Text

The Full Text of this article is available as a PDF (55.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERKOWITZ D. BLOOD LIPID AND URIC ACID INTERRELATIONSHIPS. JAMA. 1964 Nov 30;190:856–858. doi: 10.1001/jama.1964.03070220062023. [DOI] [PubMed] [Google Scholar]
  2. Bonora E., Targher G., Zenere M. B., Saggiani F., Cacciatori V., Tosi F., Travia D., Zenti M. G., Branzi P., Santi L. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord. 1996 Nov;20(11):975–980. [PubMed] [Google Scholar]
  3. Cappuccio F. P., Strazzullo P., Farinaro E., Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA. 1993 Jul 21;270(3):354–359. [PubMed] [Google Scholar]
  4. Carey D. G. Abdominal obesity. Curr Opin Lipidol. 1998 Feb;9(1):35–40. doi: 10.1097/00041433-199802000-00008. [DOI] [PubMed] [Google Scholar]
  5. Cigolini M., Targher G., Tonoli M., Manara F., Muggeo M., De Sandre G. Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995 Feb;19(2):92–96. [PubMed] [Google Scholar]
  6. Collantes Estevez E., Pineda Priego M., Añon Barbudo J., Sanchez Guijo P. Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse. Clin Rheumatol. 1990 Mar;9(1):28–31. doi: 10.1007/BF02030237. [DOI] [PubMed] [Google Scholar]
  7. Davidson M. B. Clinical implications of insulin resistance syndromes. Am J Med. 1995 Oct;99(4):420–426. doi: 10.1016/s0002-9343(99)80191-0. [DOI] [PubMed] [Google Scholar]
  8. Diamond H. S., Carter A. C., Feldman E. B. Abnormal regulation of carbohydrate metabolism in primary gout. Ann Rheum Dis. 1974 Nov;33(6):554–562. doi: 10.1136/ard.33.6.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Emmerson B. T. Identification of the causes of persistent hyperuricaemia. Lancet. 1991 Jun 15;337(8755):1461–1463. doi: 10.1016/0140-6736(91)93141-u. [DOI] [PubMed] [Google Scholar]
  10. Emmerson B. T., Nagel S. L., Duffy D. L., Martin N. G. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992 Mar;51(3):375–377. doi: 10.1136/ard.51.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Emmerson B. T. The management of gout. N Engl J Med. 1996 Feb 15;334(7):445–451. doi: 10.1056/NEJM199602153340707. [DOI] [PubMed] [Google Scholar]
  12. FELDMAN E. B., WALLACE S. L. HYPERTRIGLYCERIDEMIA IN GOUT. Circulation. 1964 Apr;29:SUPPL–SUPPL:513. doi: 10.1161/01.cir.29.4.508. [DOI] [PubMed] [Google Scholar]
  13. Facchini F., Chen Y. D., Hollenbeck C. B., Reaven G. M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991 Dec 4;266(21):3008–3011. [PubMed] [Google Scholar]
  14. Ferns G. A., Lanham J., Dieppe P., Galton D. J. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet. 1988 Jan;78(1):55–59. doi: 10.1007/BF00291235. [DOI] [PubMed] [Google Scholar]
  15. Gibson T., Kilbourn K., Horner I., Simmonds H. A. Mechanism and treatment of hypertriglyceridaemia in gout. Ann Rheum Dis. 1979 Feb;38(1):31–35. doi: 10.1136/ard.38.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ginsberg H., Olefsky J., Farquhar J. W., Reaven G. M. Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Ann Intern Med. 1974 Feb;80(2):143–149. doi: 10.7326/0003-4819-80-2-143. [DOI] [PubMed] [Google Scholar]
  17. Godsland I. F., Stevenson J. C. Insulin resistance: syndrome or tendency? Lancet. 1995 Jul 8;346(8967):100–103. doi: 10.1016/s0140-6736(95)92118-4. [DOI] [PubMed] [Google Scholar]
  18. Iribarren C., Folsom A. R., Eckfeldt J. H., McGovern P. G., Nieto F. J. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 1996 Jul;6(4):331–340. doi: 10.1016/s1047-2797(96)00052-x. [DOI] [PubMed] [Google Scholar]
  19. Jiao S., Kameda K., Matsuzawa Y., Tarui S. Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan. Ann Rheum Dis. 1986 Apr;45(4):308–313. doi: 10.1136/ard.45.4.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lee J., Sparrow D., Vokonas P. S., Landsberg L., Weiss S. T. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol. 1995 Aug 1;142(3):288–294. doi: 10.1093/oxfordjournals.aje.a117634. [DOI] [PubMed] [Google Scholar]
  21. Moriwaki Y., Yamamoto T., Takahashi S., Tsutsumi Z., Higashino K. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis. 1995 May;54(5):351–354. doi: 10.1136/ard.54.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Muscelli E., Natali A., Bianchi S., Bigazzi R., Galvan A. Q., Sironi A. M., Frascerra S., Ciociaro D., Ferrannini E. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996 Aug;9(8):746–752. doi: 10.1016/0895-7061(96)00098-2. [DOI] [PubMed] [Google Scholar]
  23. Ostrander L. D., Jr, Lamphiear D. E., Block W. D., Johnson B. C., Ravenscroft C., Epstein F. H. Relationship of serum lipid concentrations to alcohol consumption. Arch Intern Med. 1974 Sep;134(3):451–456. [PubMed] [Google Scholar]
  24. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  25. Roubenoff R., Klag M. J., Mead L. A., Liang K. Y., Seidler A. J., Hochberg M. C. Incidence and risk factors for gout in white men. JAMA. 1991 Dec 4;266(21):3004–3007. [PubMed] [Google Scholar]
  26. Schmidt M. I., Watson R. L., Duncan B. B., Metcalf P., Brancati F. L., Sharrett A. R., Davis C. E., Heiss G. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996 Jun;45(6):699–706. doi: 10.1016/s0026-0495(96)90134-1. [DOI] [PubMed] [Google Scholar]
  27. Solymoss B. C., Marcil M., Chaour M., Gilfix B. M., Poitras A. M., Campeau L. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol. 1995 Dec 1;76(16):1152–1156. doi: 10.1016/s0002-9149(99)80326-9. [DOI] [PubMed] [Google Scholar]
  28. Steinberg H. O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A. D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996 Jun 1;97(11):2601–2610. doi: 10.1172/JCI118709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takahashi S., Yamamoto T., Tsutsumi Z., Moriwaki Y., Yamakita J., Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997 Oct;46(10):1162–1165. doi: 10.1016/s0026-0495(97)90210-9. [DOI] [PubMed] [Google Scholar]
  30. Ter Maaten J. C., Voorburg A., Heine R. J., Ter Wee P. M., Donker A. J., Gans R. O. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997 Jan;92(1):51–58. doi: 10.1042/cs0920051. [DOI] [PubMed] [Google Scholar]
  31. Tinahones J. F., Pérez-Lindón G., C-Soriguer F. J., Pareja A., Sánchez-Guijo P., Collantes E. Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab. 1997 Apr;82(4):1188–1191. doi: 10.1210/jcem.82.4.3866. [DOI] [PubMed] [Google Scholar]
  32. VAGUE J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956 Jan-Feb;4(1):20–34. doi: 10.1093/ajcn/4.1.20. [DOI] [PubMed] [Google Scholar]
  33. Vuorinen-Markkola H., Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994 Jan;78(1):25–29. doi: 10.1210/jcem.78.1.8288709. [DOI] [PubMed] [Google Scholar]
  34. Wiedemann E., Rose H. G., Schwartz E. Plasma lipoproteins, glucose tolerance and insulin response in primary gout. Am J Med. 1972 Sep;53(3):299–307. doi: 10.1016/0002-9343(72)90172-6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES